A Study of Auxora in Patients With Severe COVID-19 Pneumonia
Trial details
- Registry ID
- NCT04345614
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Placebo-Injectable Emulsion
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Auxora in Patients With Severe COVID-19 PneumoniaNCT04345614 | CALC | Phase 2 | Completed | 2021-06-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |